海普瑞:H股公告2020-11-11
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
(深 圳 市 海 普 瑞 藥 業 集 團 股 份 有 限 公 司)
9989
OREGOVOMAB 3
2020 11 10 OncoQuest Pharmaceuticals Inc. Dual Industrial Co., Ltd.
KOSDAQ 078590.KQ OncoQuest Pharmaceuticals
OncoQuest Pharma USA, Inc. Oregovomab 3
17 140
602
FLORA-5 3
Oregovomab
FLORA-5 Gynecologic Oncology Group Foundation IQVIA
Oregovomab
OncoQuest Inc. 37.8%
OncoQuest Inc. OncoQuest Pharmaceuticals OncoQuest Inc.
OncoQuest Inc.
OncoQuest Pharmaceuticals 50.7%
1
OREGOVOMAB
Oregovomab CA 125 IgG 97
2 Oregovomab
2 Oregovomab
2 PFS 41.8
12.2 3.5 Oregovomab
50% Oregovomab
Oregovomab Gynecology Oncology (2020
156:523-529) Cancer Immunology and Immunotherapy (2020 69:383-397)
ONCOQUEST PHARMACEUTICALS
OncoQuest Pharmaceuticals
OncoQuest Pharmaceuticals CA-125 MUC1 PSA Her2/
neu 2020 4
OncoQuest Inc. OncoQuest Pharmaceuticals
OncoQuest Pharmaceuticals Oregovomab CA-125
3
2 OncoQuest Pharmaceuticals MUC1
1 OncoVent
Co. Ltd. OncoQuest Pharmaceuticals
Advanced Immune Therapeutics, Inc. E
IgE
2020 11 10
2